189 related articles for article (PubMed ID: 3435920)
1. Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity.
Airoldi M; Pedani F; Brando V; Gabriele P; Orecchia R
Chemioterapia; 1987 Dec; 6(6):390-2. PubMed ID: 3435920
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol].
Scherlacher A; Jakse R; Lehnert M
Laryngol Rhinol Otol (Stuttg); 1985 Feb; 64(2):58-61. PubMed ID: 3872391
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
Jakse R; Scherlacher A; Lehnert M; Haas J
HNO; 1986 Jun; 34(6):235-40. PubMed ID: 3744908
[TBL] [Abstract][Full Text] [Related]
5. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
6. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
[TBL] [Abstract][Full Text] [Related]
7. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Schwartz GK; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin DS; Colofiore J; Kelsen D
Cancer; 1996 Nov; 78(9):1988-95. PubMed ID: 8909321
[TBL] [Abstract][Full Text] [Related]
11. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
12. [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers].
Conroy T; Wils J; Paillot B; Wagener DJ; Burghouts JT; Fickers MM; de Graeff A; Lalisang FM
Bull Cancer; 1993 Mar; 80(3):255-60. PubMed ID: 8173178
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effect of sequential doses of methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced gastric cancer: comparison of intermediate-dose MTX with high-dose MTX].
Akazawa S; Nakajima T; Kitagawa H; Nakagawa T; Kanda Y; Futatsuki K; Suda Y; Yoshida S; Honda T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):91-8. PubMed ID: 3966810
[TBL] [Abstract][Full Text] [Related]
14. Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma.
Asaumi J
In Vivo; 1997; 11(2):147-51. PubMed ID: 9179607
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of sequential MTX/5-FU therapy for gastric cancer].
Hiraishi M; Konishi T; Makuuchi M
Gan To Kagaku Ryoho; 1995 Jul; 22(8):994-1000. PubMed ID: 7611769
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
18. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
Takahashi N; Nitta A; Kunii Y; Ota K
Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.
Ikeda M; Okada S; Ueno H; Okusaka T; Tanaka N; Kuriyama H; Yoshimori M
Hepatogastroenterology; 2000; 47(33):862-5. PubMed ID: 10919048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]